Büllesbach E E, Schwabe C
Biochemistry. 1986 Oct 7;25(20):5998-6004. doi: 10.1021/bi00368a025.
Porcine relaxins shortened at the N terminus of the A chain were produced after protection of all amino groups with the base-labile [[(methylsulfonyl)ethyl]oxy]carbonyl (Msc) protecting group. The first two amino acids were removed by cyanogen bromide digestion whereby simultaneously a free alpha-amino group was generated in position A3. The resulting des-ArgA1,MetA2-N epsilon A7,N epsilon A16,N epsilon B8-tris [[[(methylsulfonyl)ethyl]oxy]carbonyl]relaxin. was further shortened by preparative Edman degradation. The shortest derivative obtained was des-ArgA1,MetA2,ThrA3,LeuA4,SerA5,GluA6 -N epsilon A7,N epsilon A16,N epsilon B8-tris[[[(methylsulfonyl)ethyl]oxy]carbonyl]relaxin. The deprotection of the derivatives in alkaline media resulted in crude des-A(1-2)- to des-A(1-6)-relaxins, which were subsequently purified by gel filtration on Sephadex G-50 superfine followed by either ion exchange chromatography on CM-cellulose at pH 5.1 or high-performance liquid chromatography on reversed-phase columns. During the CNBr digest, a side product was isolated that was identified as the corresponding homoserine ( [HseA2]relaxin) derivative. Shortened relaxin derivatives and [HseA2]relaxin were characterized by reversed-phase chromatography, electrophoresis, end-group determination, and amino acid composition. Circular dichroism studies revealed a distinct change in the structure of relaxins that were shortened by three and more amino acid residues. In the mouse interpubic ligament assay, des-A(1-2)-relaxin and [HseA2]relaxin were fully biologically active while the bioactivity of des-A(1-3)-relaxin dropped to about 50%. Relaxins shortened by four and more amino acid residues were biologically inactive.(ABSTRACT TRUNCATED AT 250 WORDS)
在用对碱不稳定的[[(甲基磺酰基)乙基]氧基]羰基(Msc)保护基保护所有氨基后,产生了A链N端缩短的猪松弛素。通过溴化氰消化去除前两个氨基酸,同时在A3位生成一个游离的α-氨基。得到的去-ArgA1,MetA2-NεA7,NεA16,NεB8-三[[[(甲基磺酰基)乙基]氧基]羰基]松弛素通过制备性埃德曼降解进一步缩短。得到的最短衍生物是去-ArgA1,MetA2,ThrA3,LeuA4,SerA5,GluA6 -NεA7,NεA16,NεB8-三[[[(甲基磺酰基)乙基]氧基]羰基]松弛素。衍生物在碱性介质中的脱保护产生了粗制的去-A(1-2)-至去-A(1-6)-松弛素,随后通过在Sephadex G-50超细柱上进行凝胶过滤,接着在pH 5.1的CM-纤维素上进行离子交换色谱或在反相柱上进行高效液相色谱进行纯化。在溴化氰消化过程中,分离出一种副产物,鉴定为相应的高丝氨酸([HseA2]松弛素)衍生物。缩短的松弛素衍生物和[HseA2]松弛素通过反相色谱、电泳、端基测定和氨基酸组成进行表征。圆二色性研究表明,缩短三个及更多氨基酸残基的松弛素结构发生了明显变化。在小鼠耻骨间韧带试验中,去-A(1-2)-松弛素和[HseA2]松弛素具有完全的生物活性,而去-A(1-3)-松弛素的生物活性降至约50%。缩短四个及更多氨基酸残基的松弛素无生物活性。(摘要截断于250字)